 | Alimera Sciences Inc.
www.barrons.com - February 16 at 10:01 PM |
 | Alimera Sciences, Inc. Common Stock (ALIM) Institutional Holdings | Nasdaq
www.nasdaq.com - February 14 at 5:32 PM |
 | Alimera Sciences Inc (NASDAQ:ALIM) Short Interest Update
www.americanbankingnews.com - February 11 at 5:58 PM |
 | 2020-2026 Diabetic Retinopathy Treatment Market | Emerging Technology, Development, Industry Analysis and Forecasts
www.marketwatch.com - February 11 at 8:11 AM |
| Alimera Sciences Inc (NASDAQ:ALIM) Expected to Post Quarterly Sales of $14.50 Million
www.americanbankingnews.com - February 3 at 1:16 AM |
| Zacks: Analysts Expect Alimera Sciences Inc (NASDAQ:ALIM) Will Announce Earnings of -$0.37 Per Share
www.americanbankingnews.com - February 1 at 11:56 PM |
| Diabetic Retinopathy Treatment Market Emerging Technology, Development and Forecasts to 2026
www.marketwatch.com - January 30 at 6:14 AM |
 | Insider Buying: The Alimera Sciences, Inc. (NASDAQ:ALIM) Just Bought US$562k Worth Of Shares
finance.yahoo.com - January 29 at 12:20 PM |
| Insider Buying: The Alimera Sciences, Inc. (NASDAQ:ALIM) Just Bought US$562k Worth Of Shares
finance.yahoo.com - January 29 at 7:19 AM |
| Alimera Sciences, Inc 13D/A filing
finance.yahoo.com - January 27 at 8:43 AM |
| Alimera Sciences Inc (NASDAQ:ALIM) Sees Significant Drop in Short Interest
www.americanbankingnews.com - January 27 at 2:39 AM |
| Diabetic Retinopathy Treatment Market 2020 Global Trend, Segmentation and Opportunities Forecast To 2026
www.marketwatch.com - January 22 at 7:17 AM |
| Diabetic Retinopathy Treatment Market to Grow with Mounting Prevalence of Diabetes Worldwide: Fortune Business Insights™
www.marketwatch.com - January 15 at 11:57 PM |
| Alimera Sciences Refinances Its Debt Facility With Solar Capital
finance.yahoo.com - January 6 at 4:42 PM |
| Did Hedge Funds Drop The Ball On Alimera Sciences Inc (ALIM) ?
finance.yahoo.com - December 17 at 8:13 PM |
| Almira Sciences, Inc 13D filing
finance.yahoo.com - December 11 at 2:25 PM |
| Age-Related Macular Degeneration Market to asserts CMI with Major Vendors Size, Shares Estimation and Forecasts up to 2026
www.marketwatch.com - December 10 at 12:45 PM |
| Alimera Sciences to Participate in the LD Micro 12th Annual Main Event on December 10, 2019
finance.yahoo.com - December 4 at 9:24 AM |
| Alimera Announces Regulatory Approval for ILUVIEN® in Benelux Countries for The Treatment of Non-Infectious Posterior Uveitis
finance.yahoo.com - December 3 at 1:15 PM |
| Alimera Sciences to Participate in the 31st Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 26 at 4:24 PM |
| Edited Transcript of ALIM earnings conference call or presentation 30-Oct-19 1:00pm GMT
finance.yahoo.com - November 20 at 8:28 AM |
| Alimera Sciences Announces Effectiveness of Previously Announced Reverse Stock Split
finance.yahoo.com - November 14 at 3:21 PM |
| Alimera Sciences Terminates Equity Purchase Agreement
finance.yahoo.com - November 13 at 8:30 AM |
 | Alimera Sciences announces reverse stock split
seekingalpha.com - November 8 at 7:49 AM |
| Alimera Sciences Announces Board’s Approval of Reverse Stock Split Ratio
finance.yahoo.com - November 7 at 7:17 PM |
| One Thing To Remember About The Alimera Sciences, Inc. (NASDAQ:ALIM) Share Price
finance.yahoo.com - November 5 at 9:21 AM |
| Alimera Sciences to Participate in the 10th Annual Craig-Hallum Alpha Select Conference in New York
finance.yahoo.com - November 5 at 9:21 AM |
| Alimera Sciences, Inc. (ALIM) CEO Richard Eiswirth on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - October 30 at 5:40 PM |
| Alimera Sciences Announces Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - October 29 at 7:28 PM |
| Alimera Sciences Announces Equity Purchase Agreement for up to $20 Million with Lincoln Park Capital
finance.yahoo.com - October 25 at 1:00 PM |
| Alimera Sciences to Report Third Quarter 2019 Financial Results on Tuesday, October 29, 2019 and Provide Corporate Update
finance.yahoo.com - October 23 at 1:15 PM |
| Alimera Obtains Marketing Authorization for ILUVIEN® in Portugal for the Treatment of Non-Infectious Posterior Uveitis
finance.yahoo.com - October 3 at 8:42 AM |
| Alimera Sciences Announces Top Line Revenue Expectation For the Third Quarter of 2019
finance.yahoo.com - October 2 at 5:16 PM |
| Alimera Sciences Announces Clinical Data Featuring the Benefits of ILUVIEN® to be Presented at the American Academy of Ophthalmology Annual Meeting
finance.yahoo.com - October 1 at 8:27 AM |
| Alimera expands Iluvien distribution deal with Horus; shares ahead 10%
seekingalpha.com - September 12 at 11:18 AM |
| Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN® in Benelux Countries
finance.yahoo.com - September 12 at 11:18 AM |
 | BRIEF-Alimera Sciences Board Of Directors Approves Reverse Stock Split And 10B5-1 Stock Purchase Plan For U.S. Executive Management
www.msn.com - September 6 at 7:49 AM |
| Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
www.nasdaq.com - September 6 at 7:49 AM |
| Alimera Sciences Launches ILUVIEN® in Germany For Non-Infectious Uveitis Indication
finance.yahoo.com - September 3 at 11:29 AM |
| Retinal Drugs and Biologics Market Growth Predictions, Leading Players-ALLERGAN, AbbVie and Alimera Sciences
www.marketwatch.com - August 29 at 8:29 AM |
| How Much Of Alimera Sciences, Inc. (NASDAQ:ALIM) Do Institutions Own?
finance.yahoo.com - August 6 at 10:34 AM |
| Alimera's ILUVIEN now approved in Australia for DME
seekingalpha.com - August 5 at 10:22 AM |
| Advanced Ophthalmology Technologies Market Forecast to 2029 | Profiling Global Players- Novartis, Abbott Medical Optics and Alimera Sciences
www.marketwatch.com - August 5 at 10:22 AM |
| Alimera Announces ILUVIEN® Regulatory Approval in Australia for the Treatment of Diabetic Macular Edema
finance.yahoo.com - August 5 at 10:22 AM |
| Edited Transcript of ALIM earnings conference call or presentation 30-Jul-19 1:00pm GMT
finance.yahoo.com - July 31 at 10:01 PM |
| Alimera Sciences EPS misses by $0.03, misses on revenue
seekingalpha.com - July 30 at 11:09 AM |
| Alimera Sciences Announces Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - July 29 at 10:19 PM |
| Eye Disorders Treatments Market Forecast to 2029 | Profiling Global Players - Novartis, Abbott Medical Optics and Alimera Sciences
www.marketwatch.com - July 29 at 9:05 AM |
| Alimera Sciences Announces Multiple Papers “On Demand” at the 2019 American Society of Retina Specialists Annual Meeting
finance.yahoo.com - July 23 at 12:15 PM |
| Alimera Sciences to Report Second Quarter Financial Results on Monday, July 29, 2019 and Provide Corporate Update
finance.yahoo.com - July 22 at 10:38 AM |
